SKG Future Wearable Health Technology Co., Ltd. 2024 Half Year Report Innovation Driven · Large Product Strategy Leading Wearable Intelligent Device Manufacturing, Eye Protection Devices, Eye Massagers, Eye Massage Devices, Beauty Devices, Collagen Light Beauty Devices, Factory
Future Wearable Health Technology Co., Ltd.
SKG Health Technologies Co.,Ltd.
RMB 594.6M +8.81%
RMB 109.1M +24.84%
RMB 42.02M 7.07% of revenue
2,007 including inventions
Lumbar/eye massagers maintain leading e-commerce share.
✔ Three-level technology pre‑research system.
R&D Model
User-need oriented, hero product strategy combining differentiation and tech iteration. "Research one generation, reserve one generation, produce one generation". High-intensity R&D builds core competitiveness.
Omni-channel sales
Distribution-led (>90% of main revenue) + direct sales. Online & offline integrated network. Increase in Douyin promotion drove sales expenses +35.9%, but boosted brand exposure.
Industry tailwind
Wearable health devices CAGR ~13.8% (2024-2029). Health & wellness top 3 youth consumption. SKG leading position in cervical/lumbar massagers on major platforms.
Drafted industry standard for low-frequency massagersCIP -98.7% to RMB 3.28M as digital plant transferred.
Also recognized as Guangdong IP demonstration enterprise.
Granted Feb 2024, covering core talents. Total options representing 4.98% of share capital. Employee shareholding platform (Xiaoe Lake) also implemented.
Red Dot Award, iF Design Award. Original design philosophy "useful, easy-to-use, frequent-use". Brand image: health, tech, fashion, professional.
Wholly-owned subsidiary, total assets RMB 436.7M, net profit RMB 0.74M in H1. Operates Future Health digital factory with enhanced smart manufacturing.
Fixed assets surge after construction completionUSA (WAVE E-COMMERCE, SKG HEALTH NEW YORK), Singapore (FUTURE HEALTH TECH), Hong Kong (SKG CO., LIMITED). Newly established Hainan subsidiary as global trading node. Overseas revenue declined due to smartwatch adjustment.
Plaintiff claims ~RMB 21.98M damages. Company engaged legal opinion indicating low likelihood of infringement. The case has not yet been heard; no material adverse impact expected.
Other litigationGuangdong Shiki contract dispute ended with favorable second instance judgment; no material impact.
Controlling shareholders, directors, supervisors strictly abide by lock-up, non-competition, related-party transaction reduction commitments. No overdue commitments.
Revenue +8.8%
Net profit +24.8%
Gross margin 51.9%
ROE 15.9%
2,007 patents
R&D 7% of revenue
High-tech & SRDI
“1+M” innovation
Omni-channel, distribution-led
Douyin investment ↑
Overseas optimization
Top in cervical/lumbar massagers
Digital plant online (CIP→FA)
Liability ratio 40.2%↓
Strong retained earnings
Subsidiaries expanding
Patent lawsuit (non-material)
Competition, talent retention
Equity incentive plans active
Impressive gross margin expansion and profit growth despite higher sales expenses. The manufacturing base completion should support future scale-up.
Strong R&D culture and 2000+ patents. SKG is leading the smart massage device category. Hope the patent litigation gets resolved soon.
Cash flow decline due to marketing investment – but if it captures larger online share, acceptable trade-off. Keep watching international recovery.